Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability is a research paper published in Drug Metabolism and Disposition (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA093373
NIGMS NIH HHS
Grant: T32 GM099608
NIGMS NIH HHS
Grant: R01 GM113888
NCI NIH HHS
Grant: R01 CA225958
National Institutes of Health
Grant: 3P30CA093373-07S2
Cancer Center Support Grant - P30
National Institutes of Health
Grant: 5R01CA225958-02
Novel bioengineered microRNA therapeutics for lung cancer
National Institutes of Health
Grant: 7K08CA001124-02
DNA TOPOISOMERASE ACTIVITY AND CANCER THERAPY
National Institutes of Health
Grant: 5T32GM099608-04
Pharmacology Training: Bench to Bedside
National Institutes of Health
Grant: 5R01GM113888-03
Recombinant microRNAs in xenobiotic disposition
FWCI
1.06
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma
Additional file 1 of Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma
Additional file 2 of Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma
Additional file 2 of Analysis on EZH2: mechanism identification of related CeRNA and its immunoassay in hepatocellular carcinoma